The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Regulatory Mechanism of MicroRNA Expression in Cancer
Open accessAbstract
Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3′ UTR of their target messenger RNA (mRNA) to suppress expression. Dysfunction of miRNAs disturbs expression of oncogenic or tumor-suppressive target genes, which is implicated in cancer pathogenesis. As such, a large number of miRNAs have been found to be downregulated or upregulated in human cancers and to function as oncomiRs or oncosuppressor miRs. Notably, the molecular mechanism underlying the dysregulation of miRNA expression in cancer has been recently uncovered. The genetic deletion or amplification and epigenetic methylation of miRNA genomic loci and the transcription factor-mediated regulation of primary miRNA often alter the landscape of miRNA expression in cancer. Dysregulation of the multiple processing steps in mature miRNA biogenesis can also cause alterations in miRNA expression in cancer. Detailed knowledge of the regulatory mechanism of miRNAs in cancer is essential for understanding its physiological role and the implications of cancer-associated dysfunction and dysregulation. In this review, we elucidate how miRNA expression is deregulated in cancer, paying particular attention to the cancer-associated transcriptional and post-transcriptional factors that execute miRNA programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
Melo, S. A., Ropero, S., Moutinho, C., Aaltonen, L. A., Yamamoto, H., Calin, G. A., Rossi, S., Fernandez, A. F., Carneiro, F., Oliveira, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.317 · Cited by 373
RetractedZhang, X., Zhao, X., Fiskus, W., Lin, J., Lwin, T., Rao, R., Zhang, Y., Chan, J. C., Fu, K., Marquez, V. E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.003 · Cited by 276
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
The Microprocessor complex mediates the genesis of microRNAs
Gregory, R. I., Yan, K.-P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., & Shiekhattar, R. (2004) · Nature · doi:10.1038/nature03120 · Cited by 2,742
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Di Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., Newman, J., Bronson, R. T., Crowley, D., Stone, J. R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.019 · Cited by 1,590
Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex
Han, J., Lee, Y., Yeom, K.-H., Nam, J.-W., Heo, I., Rhee, J.-K., Sohn, S. Y., Cho, Y., Zhang, B.-T., & Kim, V. N. (2006) · Cell · doi:10.1016/j.cell.2006.03.043 · Cited by 1,551
Argonaute proteins: key players in RNA silencing
Hutvagner, G., & Simard, M. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2321 · Cited by 1,359
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Catalanotto, C., Cogoni, C., & Zardo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101712 · Cited by 1,190
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.-Y., Deng, L., Wu, Q.-L., Zeng, Y.-X., & Shao, J.-Y. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,148
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 1,073
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., Furth, E. E., Lee, W. M., Enders, G. H., Mendell, J. T., et al. (2006) · Nature Genetics · doi:10.1038/ng1855 · Cited by 1,047
A-to-I editing of coding and non-coding RNAs by ADARs
Nishikura, K. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.4 · Cited by 1,041
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
MicroRNAs and Cancer: Short RNAs Go a Long Way
Ventura, A., & Jacks, T. (2009) · Cell · doi:10.1016/j.cell.2009.02.005 · Cited by 891
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
MicroRNA functions in stress responses
Leung, A. K. L., & Sharp, P. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.027 · Cited by 865
DICER1 Mutations in Familial Pleuropulmonary Blastoma
Hill, D. A., Ivanovich, J., Priest, J. R., Gurnett, C. A., Dehner, L. P., Desruisseau, D., Jarzembowski, J. A., Wikenheiser-Brokamp, K. A., Suarez, B. K., Whelan, A. J., et al. (2009) · Science · doi:10.1126/science.1174334 · Cited by 751
Jiang, S., Zhang, H.-W., Lu, M.-H., He, X.-H., Li, Y., Gu, H., Liu, M.-F., & Wang, E.-D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4250 · Cited by 679
Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007) · Blood · doi:10.1182/blood-2007-03-081133 · Cited by 637
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
DICER1: mutations, microRNAs and mechanisms
Foulkes, W. D., Priest, J. R., & Duchaine, T. F. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3802 · Cited by 539
Dicer recognizes the 5′ end of RNA for efficient and accurate processing
Park, J.-E., Heo, I., Tian, Y., Simanshu, D. K., Chang, H., Jee, D., Patel, D. J., & Kim, V. N. (2011) · Nature · doi:10.1038/nature10198 · Cited by 512
Hsc70/Hsp90 Chaperone Machinery Mediates ATP-Dependent RISC Loading of Small RNA Duplexes
Iwasaki, S., Kobayashi, M., Yoda, M., Sakaguchi, Y., Katsuma, S., Suzuki, T., & Tomari, Y. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.015 · Cited by 505
Song, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K., Ng, C., Beringer, G., Brikbak, N. J., Yuan, X., Cantley, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.026 · Cited by 491
Self-citationThe mutational landscape of adenoid cystic carcinoma
Ho, A. S., Kannan, K., Roy, D. M., Morris, L. G. T., Ganly, I., Katabi, N., Ramaswami, D., Walsh, L. A., Eng, S., Huse, J. T., et al. (2013) · Nature Genetics · doi:10.1038/ng.2643 · Cited by 467
Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers
Heravi-Moussavi, A., Anglesio, M. S., Cheng, S.-W. G., Senz, J., Yang, W., Prentice, L., Fejes, A. P., Chow, C., Tone, A., Kalloger, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1102903 · Cited by 466
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Su, X., Chakravarti, D., Cho, M. S., Liu, L., Gi, Y. J., Lin, Y.-L., Leung, M. L., El-Naggar, A., Creighton, C. J., Suraokar, M. B., et al. (2010) · Nature · doi:10.1038/nature09459 · Cited by 419
Circulating MicroRNAs in Cancer: Potential and Challenge
Cui, M., Wang, H., Yao, X., Zhang, D., Xie, Y., Cui, R., & Zhang, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00626 · Cited by 418
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Molenaar, J. J., Domingo-Fernández, R., Ebus, M. E., Lindner, S., Koster, J., Drabek, K., Mestdagh, P., van Sluis, P., Valentijn, L. J., van Nes, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2436 · Cited by 383
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S.-O., Du, Y., Wang, Y., Chang, W.-C., Chen, C.-H., et al. (2013) · Nature · doi:10.1038/nature12080 · Cited by 356
Davalos, V, Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.383 · Cited by 351
A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells
Melo, S. A., Moutinho, C., Ropero, S., Calin, G. A., Rossi, S., Spizzo, R., Fernandez, A. F., Davalos, V., Villanueva, A., Montoya, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.007 · Cited by 346
Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F. D., & Gregory, R. I. (2014) · Cell · doi:10.1016/j.cell.2013.12.043 · Cited by 335
MicroRNA-21: A novel therapeutic target in human cancer
Pan, X., Wang, Z.-X., & Wang, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.14252 · Cited by 322
MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
Di Leva, G., Gasparini, P., Piovan, C., Ngankeu, A., Garofalo, M., Taccioli, C., Iorio, M. V., Li, M., Volinia, S., Alder, H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq102 · Cited by 320
Ceppi, P., Mudduluru, G., Kumarswamy, R., Rapa, I., Scagliotti, G. V., Papotti, M., & Allgayer, H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0052 · Cited by 303
Wegert, J., Ishaque, N., Vardapour, R., Geörg, C., Gu, Z., Bieg, M., Ziegler, B., Bausenwein, S., Nourkami, N., Ludwig, N., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.002 · Cited by 302
Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors
Walz, A. L., Ooms, A., Gadd, S., Gerhard, D. S., Smith, M. A., Guidry Auvil, J. M., Meerzaman, D., Chen, Q.-R., Hsu, C. H., Yan, C., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.003 · Cited by 284
Hypoxia: A master regulator of microRNA biogenesis and activity
Nallamshetty, S., Chan, S. Y., & Loscalzo, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.022 · Cited by 281
Franovic, A., Gunaratnam, L., Smith, K., Robert, I., Patten, D., & Lee, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702387104 · Cited by 250
Rakheja, D., Chen, K. S., Liu, Y., Shukla, A. A., Schmid, V., Chang, T.-C., Khokhar, S., Wickiser, J. E., Karandikar, N. J., Malter, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5802 · Cited by 236
Liu, C., Liu, R., Zhang, D., Deng, Q., Liu, B., Chao, H.-P., Rycaj, K., Takata, Y., Lin, K., Lu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14270 · Cited by 228
Zhang, J., Sun, Q., Zhang, Z., Ge, S., Han, Z.-G., & Chen, W.-T. (2013) · Oncogene · doi:10.1038/onc.2012.28 · Cited by 224
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
Suh, S. O., Chen, Y., Zaman, M. S., Hirata, H., Yamamura, S., Shahryari, V., Liu, J., Tabatabai, Z. L., Kakar, S., Deng, G., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr036 · Cited by 206
Dysregulation of microRNA biogenesis machinery in cancer
Hata, A., & Kashima, R. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1117054 · Cited by 206
miR-34 and p53: New Insights into a Complex Functional Relationship
Navarro, F., & Lieberman, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132767 · Cited by 202
MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer
Liang, Y.-J., Wang, Q.-Y., Zhou, C.-X., Yin, Q.-Q., He, M., Yu, X.-T., Cao, D.-X., Chen, G.-Q., He, J.-R., & Zhao, Q. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs383 · Cited by 198
Pekarsky, Y., & Croce, C. M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.87 · Cited by 186
Epigenetic regulation of miR‐34b and miR‐129 expression in gastric cancer
Tsai, K., Wu, C., Hu, L., Li, S., Liao, Y., Lai, C., Kao, H., Fang, W., Huang, K., Chan, W., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25919 · Cited by 183
Anglesio, M., Wang, Y., Yang, W., Senz, J., Wan, A., Heravi‐Moussavi, A., Salamanca, C., Maines‐Bandiera, S., Huntsman, D., & Morin, G. (2013) · The Journal of Pathology · doi:10.1002/path.4135 · Cited by 178
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers
Wang, Y., Xu, X., Yu, S., Jeong, K. J., Zhou, Z., Han, L., Tsang, Y. H., Li, J., Chen, H., Mangala, L. S., et al. (2017) · Genome Research · doi:10.1101/gr.219741.116 · Cited by 177
Li, Y., Choi, P. S., Casey, S. C., Dill, D. L., & Felsher, D. W. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.014 · Cited by 174
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Torrezan, G. T., Ferreira, E. N., Nakahata, A. M., Barros, B. D. F., Castro, M. T. M., Correa, B. R., Krepischi, A. C. V., Olivieri, E. H. R., Cunha, I. W., Tabori, U., et al. (2014) · Nature Communications · doi:10.1038/ncomms5039 · Cited by 173
Pallasch, C. P., Patz, M., Park, Y. J., Hagist, S., Eggle, D., Claus, R., Debey-Pascher, S., Schulz, A., Frenzel, L. P., Claasen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-06-229898 · Cited by 160
ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates
Guan, T., Dominguez, C. X., Amezquita, R. A., Laidlaw, B. J., Cheng, J., Henao-Mejia, J., Williams, A., Flavell, R. A., Lu, J., & Kaech, S. M. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171352 · Cited by 159
The Role of Exportin-5 in MicroRNA Biogenesis and Cancer
Wu, K., He, J., Pu, W., & Peng, Y. (2018) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.09.004 · Cited by 158
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
Kent, O. A., Fox-Talbot, K., & Halushka, M. K. (2012) · Oncogene · doi:10.1038/onc.2012.266 · Cited by 154
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M. P., HU, J. L., Jiang, S., Fletcher-Sananikone, E., Zhuang, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.019 · Cited by 153
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5
Sun, H., Cui, R., Zhou, J., Teng, K., Hsiao, Y., Nakanishi, K., Fassan, M., Luo, Z., Shi, G., Tili, E., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.001 · Cited by 147
Alternative RISC assembly: Binding and repression of microRNA–mRNA duplexes by human Ago proteins
Janas, M. M., Wang, B., Harris, A., Aguiar, M., Shaffer, J. M., Subrahmanyam, Y. V. B. K., Behlke, M. A., Wucherpfennig, K. W., Gygi, S. P., Gagnon, É., et al. (2012) · RNA · doi:10.1261/rna.035675.112 · Cited by 144
Baer, C. R., Claus, R., Frenzel, L. P., Zucknick, M., Park, Y. J., Gu, L., Weichenhan, D., Fischer, M., Pallasch, C. P., Herpel, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0803 · Cited by 138
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
Rainer, J., Ploner, C., Jesacher, S., Ploner, A., Eduardoff, M., Mansha, M., Wasim, M., Panzer‐Grümayer, R., Trajanoski, Z., Niederegger, H., et al. (2009) · Leukemia · doi:10.1038/leu.2008.370 · Cited by 131
Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
Cittelly, D. M., Finlay-Schultz, J., Howe, E. N., Spoelstra, N. S., Axlund, S. D., Hendricks, P., Jacobsen, B. M., Sartorius, C. A., & Richer, J. K. (2012) · Oncogene · doi:10.1038/onc.2012.275 · Cited by 126
Li, J., Lai, Y., Ma, J., Liu, Y., Bi, J., Zhang, L., Chen, L., Chen, Y., Lv, W., Chang, G., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3674-x · Cited by 118
Role of let-7 family microRNA in breast cancer
Thammaiah, C. K., & Jayaram, S. (2016) · Non-coding RNA Research · doi:10.1016/j.ncrna.2016.10.003 · Cited by 114
Argonaute 2: A Novel Rising Star in Cancer Research
Ye, Z., Jin, H., & Qian, Q. (2015) · Journal of Cancer · doi:10.7150/jca.11735 · Cited by 113
Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
Gurtner, A., Falcone, E., Garibaldi, F., & Piaggio, G. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0319-x · Cited by 113
miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth
Mihailovich, M., Bremang, M., Spadotto, V., Musiani, D., Vitale, E., Varano, G., Zambelli, F., Mancuso, F. M., Cairns, D. A., Pavesi, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms9725 · Cited by 111
Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis
Zeinali, T., Mansoori, B., Mohammadi, A., & Baradaran, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.037 · Cited by 105
Muralidhar, B., Winder, D. M., Murray, M. J., Palmer, R. D., Barbosa‐Morais, N. L., Saini, H. K., Roberts, I., Pett, M. R., & Coleman, N. (2011) · The Journal of Pathology · doi:10.1002/path.2898 · Cited by 95
Wang, D., Huang, J., & Hu, Z. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011932 · Cited by 93
Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay
Fish, L., Navickas, A., Culbertson, B., Xu, Y., Nguyen, H. C. B., Zhang, S., Hochman, M., Okimoto, R. A., Dill, B. D., Molina, H., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.001 · Cited by 93
Ramírez-Moya, J., Wert-Lamas, L., Riesco‐Eizaguirre, G., & Santisteban, P. (2019) · Oncogene · doi:10.1038/s41388-019-0804-8 · Cited by 91
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma
Manier, S., Powers, J. T., Sacco, A., Glavey, S. V., Huynh, D., Reagan, M. R., Salem, K. Z., Moschetta, M., Shi, J., Mishima, Y., et al. (2016) · Leukemia · doi:10.1038/leu.2016.296 · Cited by 89
Gong, J., Wu, Y., Zhang, X., Liao, Y., Sibanda, V. L., Liu, W., & Guo, A. (2014) · RNA Biology · doi:10.1080/15476286.2014.996465 · Cited by 87
Coarfa, C., Fiskus, W. C., Eedunuri, V. K., Rajapakshe, K., Foley, C., Chew, S. A., Shah, S. S., Geng, C., Shou, J., Mohamed, J. S., et al. (2015) · Oncogene · doi:10.1038/onc.2015.295 · Cited by 82
Schmid, G., Notaro, S., Reimer, D., Abdel-Azim, S. A.-F., Duggan-Peer, M., Holly, J., Fiegl, H., Rössler, J., Wiedemair, A., Concin, N., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2135-2 · Cited by 82
Pinho, F. G., Frampton, A. E., Nunes, J., Krell, J., Alshaker, H. A., Jacob, J., Pellegrino, L., Roca-Alonso, L., de Giorgio, A., Harding, V., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0158 · Cited by 80
microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)
Yang (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.970 · Cited by 79
Finlay-Schultz, J., Cittelly, D. M., Hendricks, P., Patel, P., Kabos, P., Jacobsen, B. M., Richer, J. K., & Sartorius, C. A. (2014) · Oncogene · doi:10.1038/onc.2014.298 · Cited by 78
MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis
Wang, W., Li, J., Zhu, W. J., Gao, C., Jiang, R., Li, W., Hu, Q., & Zhang, B. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-819 · Cited by 78
Chen, W., Wang, H., Chen, H., Liu, S., Lu, H., Kong, D., Huang, X., Kong, Q., & Lu, Z. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12263 · Cited by 76
Lambert, M.-P., Terrone, S., Giraud, G., Benoit‐Pilven, C., Cluet, D., Combaret, V., Mortreux, F., Auboeuf, D., & Bourgeois, C. F. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky545 · Cited by 75
Higuchi, T., Todaka, H., Sugiyama, Y., Ono, M., Tamaki, N., Hatano, E., Takezaki, Y., Hanazaki, K., Miwa, T., Lai, S., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.748210 · Cited by 73
Allegra, D., Bilan, V., Garding, A., Döhner, H., Stilgenbauer, S., Kuchenbauer, F., Mertens, D., & Zucknick, M. (2013) · Leukemia · doi:10.1038/leu.2013.246 · Cited by 71
Wendler (2010) · Oncology Reports · doi:10.3892/or_00001071 · Cited by 67
Zuo, J., Yu, Y., Zhu, M., Jing, W., Yu, M., Chai, H., Liang, C., & Tu, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170642 · Cited by 66
MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma
Zhang, J., Jin, H., Liu, H., Lv, S., Wang, B., Wang, R., Liu, H., Ding, M., Yang, Y., Li, L., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.11 · Cited by 63
Temporal and Spatial Regulation of miR-320 in the Uterus during Embryo Implantation in the Rat
Xia, H., Jin, X.-H., Song, P., Cui, Y., Liu, C., & Ma, X. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11020719 · Cited by 60
Gynecologic Manifestations of the DICER1 Syndrome
Stewart, C. J. R., CHARLES, A. K., & Foulkes, W. D. (2016) · Surgical pathology clinics · doi:10.1016/j.path.2016.01.002 · Cited by 52
Up-regulation of Ago2 expression in gastric carcinoma
Zhang, J., Fan, X., Wang, C., Liu, B., Li, Q., & Zhou, X. (2013) · Medical Oncology · doi:10.1007/s12032-013-0628-2 · Cited by 51
Role of microRNA-146a in normal and malignant hematopoietic stem cell function
Zhao, J. L., & Starczynowski, D. T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00219 · Cited by 47
Germline and somatic DICER1 mutations in familial and sporadic liver tumors
Caruso, S., Caldéraro, J., Letouzé, É., Nault, J., Couchy, G., Boulai, A., Luciani, A., Zafrani, E., Bioulac‐Sage, P., Séror, O., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.010 · Cited by 44
When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference
Wang, Y., & Liang, H. (2017) · BioEssays · doi:10.1002/bies.201700188 · Cited by 43
Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer
Shindo, T., Niinuma, T., Nishiyama, N., Shinkai, N., Kitajima, H., Kai, M., Maruyama, R., Tokino, T., Masumori, N., & Suzuki, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25326 · Cited by 42
MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
Chen, P., Guo, X., Zhang, L., Zhang, W., Zhou, Q. S., Tian, Z., Zheng, Y., Liao, Q., Wang, H., Li, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14123 · Cited by 41
Fernández-Martínez, L., Villegas-Rubio, J. A., Santamaría, Í., Pitiot, A. S., Alvarado, M. G., Fernández, S., Rivas, H. E. T., Paredes, Á., Blay, P., & Balbín, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3136-5 · Cited by 40
NF90 modulates processing of a subset of human pri-miRNAs
Grasso, G. I., Higuchi, T., Mac, V., Barbier, J., Helsmoortel, M., Lorenzi, C., Sanchez, G., Bello, M., Ritchie, W., Sakamoto, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa386 · Cited by 40
Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
Takayama, K., Misawa, A., & Inoue, S. (2017) · Cancers · doi:10.3390/cancers9080102 · Cited by 39
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
Casey, M., Prakash, A., Holian, E., McGuire, A., Kalinina, O., Shalaby, A., Curran, C. E., Webber, M., Callagy, G. M., Bourke, E., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5884-x · Cited by 37
Lee, J., Kim, H. E., Song, Y., Cho, E. Y., & Lee, A. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05192-1 · Cited by 33
Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study
Schrijver, W. A. M. E., van Diest, P. J., & Moelans, C. B. (2016) · Oncotarget · doi:10.18632/oncotarget.13623 · Cited by 31
Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer
Garré, P., Pérez‐Segura, P., Díaz‐Rubio, E., Caldés, T., & de la Hoya, M. (2010) · Nature Genetics · doi:10.1038/ng1010-817 · Cited by 29
Seipel, K., Messerli, C., Wiedemann, G., Bacher, U., & Pabst, T. (2020) · Leukemia Research · doi:10.1016/j.leukres.2020.106296 · Cited by 28
Zhang, Y., Wang, B., Chen, X., Li, W., & Dong, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18047 · Cited by 27
Intracytoplasmic Re-localization of miRISC Complexes
Akgül, B., & Erdoğan, İ. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00403 · Cited by 27
Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.
Yang, F., Huang, J., Liu, M., Yang, F., Li, W., Wang, G., Che, J., & Zheng, J. (2014) · Europe PMC (PubMed Central) · Cited by 24
Wang, D., Division, L. S., Hu, Z., & Hu, Z. (2011) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/1062099 · Cited by 9
Cited by
miRNA interplay: mechanisms and consequences in cancer
Hill, M., & Tran, N. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047662 · Cited by 674
Circulating MicroRNAs in Cancer: Potential and Challenge
Cui, M., Wang, H., Yao, X., Zhang, D., Xie, Y., Cui, R., & Zhang, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00626 · Cited by 418
RNAi-based therapeutics and tumor targeted delivery in cancer
Kara, G., Calin, G. A., & Ozpolat, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114113 · Cited by 411
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
Annese, T., Tamma, R., De Giorgis, M., & Ribatti, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581007 · Cited by 288
Metadata
- Authors
- Ali Syeda, Z., Langden, S. S. S., Munkhzul, C., Lee, M., & Song, S. J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-03-03
- Volume
- 21
- Issue
- 5
- Pages
- 1723
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3010560689
- Cited by
- 995
- References
- 124
- FWCI
- 40.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.